{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:10:37Z","timestamp":1794003037070,"version":"4.8.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771250"],"award-info":[{"award-number":["81771250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2023Y9286"],"award-info":[{"award-number":["2023Y9286"]}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2024J011004"],"award-info":[{"award-number":["2024J011004"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03709-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:16:43Z","timestamp":1770265003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The immunoproteasome as a neuroimmune hub in the central nervous system: from proteostasis stress to inflammatory pathology"],"prefix":"10.1186","volume":"23","author":[{"given":"Huiying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"4","key":"3709_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12017-023-08755-0","volume":"25","author":"Y Liang","year":"2023","unstructured":"Liang Y, Zhong G, Ren M, Sun T, Li Y, Ye M, et al. The role of Ubiquitin-Proteasome system and mitophagy in the pathogenesis of parkinson\u2019s disease. Neuromol Med. 2023;25(4):471\u201388.","journal-title":"NEUROMOL MED"},{"issue":"6624","key":"3709_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/386463a0","volume":"386","author":"M Groll","year":"1997","unstructured":"Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, et al. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 1997;386(6624):463\u201371.","journal-title":"Nature"},{"issue":"3","key":"3709_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35056572","volume":"2","author":"PM Kloetzel","year":"2001","unstructured":"Kloetzel PM. Antigen processing by the proteasome. Nat Rev Mol Cell BIO. 2001;2(3):179\u201387.","journal-title":"NAT REV MOL CELL BIO"},{"issue":"11","key":"3709_CR4","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1172\/JCI29832","volume":"116","author":"E Shin","year":"2006","unstructured":"Shin E, Seifert U, Kato T, Rice CM, Feinstone SM, Kloetzel P, et al. Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest. 2006;116(11):3006\u201314.","journal-title":"J CLIN INVEST"},{"issue":"2","key":"3709_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2353\/ajpath.2009.090033","volume":"175","author":"S Jakel","year":"2009","unstructured":"Jakel S, Kuckelkorn U, Szalay G, Plotz M, Textoris-Taube K, Opitz E, et al. Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol. 2009;175(2):510\u20138.","journal-title":"AM J PATHOL"},{"key":"3709_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","volume":"109","author":"DA Ferrington","year":"2012","unstructured":"Ferrington DA, Gregerson DS. Immunoproteasomes: structure, function, and antigen presentation. Prog Mol Biol Transl. 2012;109:75\u2013112.","journal-title":"PROG MOL BIOL TRANSL"},{"issue":"4","key":"3709_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","volume":"142","author":"U Seifert","year":"2010","unstructured":"Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schroter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell. 2010;142(4):613\u201324.","journal-title":"Cell"},{"issue":"7","key":"3709_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm.1978","volume":"15","author":"T Muchamuel","year":"2009","unstructured":"Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, Lauer C, et al. A selective inhibitor of the Immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med. 2009;15(7):781\u20137.","journal-title":"NAT MED"},{"issue":"1","key":"3709_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coi.2012.11.004","volume":"25","author":"M Basler","year":"2013","unstructured":"Basler M, Kirk CJ, Groettrup M. The Immunoproteasome in antigen processing and other immunological functions. Curr Opin Immunol. 2013;25(1):74\u201380.","journal-title":"CURR OPIN IMMUNOL"},{"key":"3709_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-biochem-060410-150257","volume":"82","author":"RJJ Tomko","year":"2013","unstructured":"Tomko RJJ, Hochstrasser M. Molecular architecture and assembly of the eukaryotic proteasome. Annu Rev Biochem. 2013;82:415\u201345.","journal-title":"ANNU REV BIOCHEM"},{"issue":"8","key":"3709_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00018-023-04867-9","volume":"80","author":"H Su","year":"2023","unstructured":"Su H, Li P, Shi K, Gao J, Zhang H, Li H. The Immunoproteasome subunit beta2i ameliorates myocardial ischemia\/reperfusion injury by regulating Parkin-Mfn1\/2-mediated mitochondrial fusion. Cell Mol Life Sci. 2023;80(8):231.","journal-title":"CELL MOL LIFE SCI"},{"issue":"1","key":"3709_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41420-025-02698-0","volume":"11","author":"Z Zou","year":"2025","unstructured":"Zou Z, Hao Y, Tao Z, Ye W, Luo Z, Li X, et al. Current landscape of the immunoproteasome: implications for disease and therapy. Cell Death Discov. 2025;11(1):406.","journal-title":"CELL DEATH DISCOV"},{"key":"3709_CR13","doi-asserted-by":"crossref","unstructured":"Collins GA, Goldberg AL. The Logic of the 26S Proteasome. Cell. 2017;169(5):792\u2013806.","DOI":"10.1016\/j.cell.2017.04.023"},{"key":"3709_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1146\/annurev-biochem-062917-011931","volume":"87","author":"JAM Bard","year":"2018","unstructured":"Bard JAM, Goodall EA, Greene ER, Jonsson E, Dong KC, Martin A. Structure and function of the 26S proteasome. Annu Rev Biochem. 2018;87:697\u2013724.","journal-title":"ANNU REV BIOCHEM"},{"key":"3709_CR15","doi-asserted-by":"crossref","unstructured":"Sahu I, Glickman MH. Structural insights into substrate recognition and processing by the 20S proteasome. Biomolecules. 2021;11(2):148.","DOI":"10.3390\/biom11020148"},{"key":"3709_CR16","doi-asserted-by":"crossref","unstructured":"Kisselev AF. Site-Specific Proteasome Inhibitors. Biomolecules. 2021;12(1):54.","DOI":"10.3390\/biom12010054"},{"issue":"26","key":"3709_CR17","doi-asserted-by":"publisher","first-page":"9241","DOI":"10.1073\/pnas.0501711102","volume":"102","author":"S Heink","year":"2005","unstructured":"Heink S, Ludwig D, Kloetzel P, Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. P Natl Acad Sci USA. 2005;102(26):9241\u20136.","journal-title":"P NATL ACAD SCI USA"},{"issue":"1","key":"3709_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/jem.187.1.97","volume":"187","author":"TA Griffin","year":"1998","unstructured":"Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monaco JJ, et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med. 1998;187(1):97\u2013104.","journal-title":"J EXP MED"},{"key":"3709_CR19","doi-asserted-by":"crossref","unstructured":"Basler M, Groettrup M. On the role of the Immunoproteasome in protein homeostasis. Cells. 2021;10(11):3216.","DOI":"10.3390\/cells10113216"},{"issue":"5176","key":"3709_CR20","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.8066463","volume":"265","author":"HJ Fehling","year":"1994","unstructured":"Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U, et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science. 1994;265(5176):1234\u20137.","journal-title":"Science"},{"key":"3709_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","volume":"78","author":"D Finley","year":"2009","unstructured":"Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem. 2009;78:477\u2013513.","journal-title":"ANNU REV BIOCHEM"},{"issue":"9","key":"3709_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00018-011-0657-y","volume":"68","author":"EJAM Sijts","year":"2011","unstructured":"Sijts EJAM, Kloetzel PM. The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci. 2011;68(9):1491\u2013502.","journal-title":"CELL MOL LIFE SCI"},{"issue":"9","key":"3709_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41590-018-0186-z","volume":"19","author":"S Murata","year":"2018","unstructured":"Murata S, Takahama Y, Kasahara M, Tanaka K. The Immunoproteasome and thymoproteasome: functions, evolution and human disease. Nat Immunol. 2018;19(9):923\u201331.","journal-title":"NAT IMMUNOL"},{"key":"3709_CR24","doi-asserted-by":"crossref","unstructured":"Oliveri F, Mink D, Muchamuel T, Basler M. Immunoproteasome Inhibition impairs differentiation but not survival of T helper 17 cells. Cells. 2025;14(10):689.","DOI":"10.3390\/cells14100689"},{"issue":"1","key":"3709_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4049\/jimmunol.0903182","volume":"185","author":"M Basler","year":"2010","unstructured":"Basler M, Dajee M, Moll C, Groettrup M, Kirk CJ. Prevention of experimental colitis by a selective inhibitor of the Immunoproteasome. J Immunol. 2010;185(1):634\u201341.","journal-title":"J IMMUNOL"},{"issue":"8","key":"3709_CR26","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.4049\/jimmunol.0903003","volume":"184","author":"SE Hensley","year":"2010","unstructured":"Hensley SE, Zanker D, Dolan BP, David A, Hickman HD, Embry AC, et al. Unexpected role for the Immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol. 2010;184(8):4115\u201322.","journal-title":"J IMMUNOL"},{"issue":"6","key":"3709_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/pin.13088","volume":"71","author":"M Kasahara","year":"2021","unstructured":"Kasahara M. Role of immunoproteasomes and thymoproteasomes in health and disease. Pathol Int. 2021;71(6):371\u201382.","journal-title":"PATHOL INT"},{"issue":"11","key":"3709_CR28","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.4049\/jimmunol.176.11.6665","volume":"176","author":"M Basler","year":"2006","unstructured":"Basler M, Moebius J, Elenich L, Groettrup M, Monaco JJ. An altered T cell repertoire in MECL-1-deficient mice. J Immunol. 2006;176(11):6665\u201372.","journal-title":"J IMMUNOL"},{"issue":"2","key":"3709_CR29","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4049\/jimmunol.175.2.1153","volume":"175","author":"AK Nussbaum","year":"2005","unstructured":"Nussbaum AK, Rodriguez-Carreno MP, Benning N, Botten J, Whitton JL. Immunoproteasome-deficient mice Mount largely normal CD8\u2009+\u2009T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J Immunol. 2005;175(2):1153\u201360.","journal-title":"J IMMUNOL"},{"issue":"31","key":"3709_CR30","doi-asserted-by":"publisher","first-page":"24156","DOI":"10.1074\/jbc.M001742200","volume":"275","author":"DJ Kingsbury","year":"2000","unstructured":"Kingsbury DJ, Griffin TA, Colbert RA. Novel propeptide function in 20 S proteasome assembly influences beta subunit composition. J Biol Chem. 2000;275(31):24156\u201362.","journal-title":"J BIOL CHEM"},{"key":"3709_CR31","doi-asserted-by":"publisher","unstructured":"Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014;2014:761264. https:\/\/doi.org\/10.1155\/2014\/761264.","DOI":"10.1155\/2014\/761264"},{"issue":"1","key":"3709_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.coi.2012.01.005","volume":"24","author":"E Kruger","year":"2012","unstructured":"Kruger E, Kloetzel P. Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr Opin Immunol. 2012;24(1):77\u201383.","journal-title":"CURR OPIN IMMUNOL"},{"issue":"5","key":"3709_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0092-8674(94)90462-6","volume":"78","author":"KL Rock","year":"1994","unstructured":"Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78(5):761\u201371.","journal-title":"Cell"},{"issue":"15","key":"3709_CR34","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00018-012-0938-0","volume":"69","author":"F Ebstein","year":"2012","unstructured":"Ebstein F, Kloetzel P, Kruger E, Seifert U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell Mol Life Sci. 2012;69(15):2543\u201358.","journal-title":"CELL MOL LIFE SCI"},{"issue":"1","key":"3709_CR35","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1038\/s41467-023-39642-8","volume":"14","author":"M Kim","year":"2023","unstructured":"Kim M, Serwa RA, Samluk L, Suppanz I, Kodron A, Stepkowski TM, et al. Immunoproteasome-specific subunit PSMB9 induction is required to regulate cellular proteostasis upon mitochondrial dysfunction. Nat Commun. 2023;14(1):4092.","journal-title":"NAT COMMUN"},{"issue":"4","key":"3709_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cell.2010.08.002","volume":"142","author":"S van Deventer","year":"2010","unstructured":"van Deventer S, Neefjes J. The Immunoproteasome cleans up after inflammation. Cell. 2010;142(4):517\u20138.","journal-title":"Cell"},{"key":"3709_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-397863-9.00006-7","volume":"109","author":"AM Pickering","year":"2012","unstructured":"Pickering AM, Davies KJA. Degradation of damaged proteins: the main function of the 20S proteasome. Prog Mol Biol Transl. 2012;109:227\u201348.","journal-title":"PROG MOL BIOL TRANSL"},{"key":"3709_CR38","doi-asserted-by":"crossref","unstructured":"Abi Habib J, Lesenfants J, Vigneron N, Van den Eynde BJ. Functional differences between proteasome subtypes. Cells. 2022;11(3):421.","DOI":"10.3390\/cells11030421"},{"issue":"4 Suppl 92","key":"3709_CR39","first-page":"S74","volume":"33","author":"M Basler","year":"2015","unstructured":"Basler M, Mundt S, Bitzer A, Schmidt C, Groettrup M. The immunoproteasome: a novel drug target for autoimmune diseases. Clin Exp Rheumatol. 2015;33(4 Suppl 92):S74\u20139.","journal-title":"CLIN EXP RHEUMATOL"},{"issue":"2","key":"3709_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/emmm.201303543","volume":"6","author":"M Basler","year":"2014","unstructured":"Basler M, Mundt S, Muchamuel T, Moll C, Jiang J, Groettrup M, et al. Inhibition of the Immunoproteasome ameliorates experimental autoimmune encephalomyelitis. Embo Mol Med. 2014;6(2):226\u201338.","journal-title":"EMBO MOL MED"},{"issue":"3","key":"3709_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1042\/BJ20100878","volume":"432","author":"AM Pickering","year":"2010","unstructured":"Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, Davies KJA. The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J. 2010;432(3):585\u201394.","journal-title":"BIOCHEM J"},{"issue":"11","key":"3709_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41419-024-07189-1","volume":"15","author":"H Su","year":"2024","unstructured":"Su H, Xu L, Li P, Bi H, Jiang W, Li H. Psmb8 inhibits mitochondrial fission and alleviates myocardial ischaemia\/reperfusion injury by targeting Drp1 degradation. Cell Death Dis. 2024;15(11):803.","journal-title":"CELL DEATH DIS"},{"key":"3709_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2024.03.026","volume":"218","author":"C Ott","year":"2024","unstructured":"Ott C. Mapping the interplay of Immunoproteasome and autophagy in different heart failure phenotypes. Free Radical Bio Med. 2024;218:149\u201365.","journal-title":"FREE RADICAL BIO MED"},{"key":"3709_CR44","doi-asserted-by":"publisher","first-page":"1603816","DOI":"10.3389\/fimmu.2025.1603816","volume":"16","author":"D Beland","year":"2025","unstructured":"Beland D, Viens M, Kalin EM, Bourgeois-Daigneault M. From oncogenesis to prognosis: the roles of the Immunoproteasome in cancer. Front Immunol. 2025;16:1603816.","journal-title":"FRONT IMMUNOL"},{"issue":"5","key":"3709_CR45","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.2741\/4027","volume":"17","author":"A Angeles","year":"2012","unstructured":"Angeles A, Fung G, Luo H. Immune and non-immune functions of the Immunoproteasome. Front Biosci-landmrk. 2012;17(5):1904\u201316.","journal-title":"FRONT BIOSCI-LANDMRK"},{"issue":"1","key":"3709_CR46","doi-asserted-by":"publisher","first-page":"e1626","DOI":"10.1038\/cddis.2014.586","volume":"6","author":"X Chen","year":"2015","unstructured":"Chen X, Zhang X, Wang Y, Lei H, Su H, Zeng J, et al. Inhibition of Immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke. Cell Death Dis. 2015;6(1):e1626.","journal-title":"CELL DEATH DIS"},{"issue":"1","key":"3709_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40779-021-00356-x","volume":"8","author":"X Chen","year":"2021","unstructured":"Chen X, Wan S, Yao N, Lin Z, Mao Y, Yu X, et al. Inhibition of the Immunoproteasome LMP2 ameliorates ischemia\/hypoxia-induced blood-brain barrier injury through the Wnt\/beta-catenin signalling pathway. Military Med Res. 2021;8(1):62.","journal-title":"MILITARY MED RES"},{"key":"3709_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbi.2018.04.009","volume":"73","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang X, Chen T, Jiang X, Wang X, Lei H, et al. Inhibition of Immunoproteasome promotes angiogenesis via enhancing hypoxia-inducible factor-1alpha abundance in rats following focal cerebral ischaemia. Brain Behav Immun. 2018;73:167\u201379.","journal-title":"BRAIN BEHAV IMMUN"},{"issue":"2","key":"3709_CR49","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/jcmm.17104","volume":"26","author":"X Chen","year":"2022","unstructured":"Chen X, Wang Y, Yao N, Lin Z. Immunoproteasome modulates NLRP3 inflammasome-mediated neuroinflammation under cerebral ischaemia and reperfusion conditions. J Cell Mol Med. 2022;26(2):462\u201374.","journal-title":"J CELL MOL MED"},{"issue":"34","key":"3709_CR50","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.2174\/092986709789760779","volume":"16","author":"H Shi","year":"2009","unstructured":"Shi H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem. 2009;16(34):4593\u2013600.","journal-title":"CURR MED CHEM"},{"issue":"4","key":"3709_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10571-012-9803-9","volume":"32","author":"N Singh","year":"2012","unstructured":"Singh N, Sharma G, Mishra V. Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol. 2012;32(4):491\u2013507.","journal-title":"CELL MOL NEUROBIOL"},{"issue":"Pt 11","key":"3709_CR52","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1093\/brain\/aws269","volume":"135","author":"TR Doeppner","year":"2012","unstructured":"Doeppner TR, Mlynarczuk-Bialy I, Kuckelkorn U, Kaltwasser B, Herz J, Hasan MR, et al. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain. 2012;135(Pt 11):3282\u201397.","journal-title":"Brain"},{"issue":"7","key":"3709_CR53","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.4103\/1673-5374.386398","volume":"19","author":"X Chen","year":"2024","unstructured":"Chen X, Yao N, Mao Y, Xiao D, Huang Y, Zhang X, et al. Activation of the Wnt\/beta-catenin\/CYP1B1 pathway alleviates oxidative stress and protects the blood-brain barrier under cerebral ischemia\/reperfusion conditions. Neural Regen Res. 2024;19(7):1541\u20137.","journal-title":"NEURAL REGEN RES"},{"key":"3709_CR54","doi-asserted-by":"publisher","unstructured":"Chen X, Yao N, Lin Z, Wang Y. Inhibition of the Immunoproteasome Subunit LMP7 Ameliorates Cerebral White Matter Demyelination Possibly via TGFbeta\/Smad Signaling. Evid-based Compl Alt. 2021;2021:6426225. https:\/\/doi.org\/10.1155\/2021\/6426225.","DOI":"10.1155\/2021\/6426225"},{"issue":"4","key":"3709_CR55","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4103\/1673-5374.295344","volume":"16","author":"X Chen","year":"2021","unstructured":"Chen X, Fu M, Wan S, Zhang X, Wang Y. Association between plasma Immunoproteasome and 90-day prognosis after first-ever ischemic stroke. Neural Regen Res. 2021;16(4):790\u20135.","journal-title":"NEURAL REGEN RES"},{"issue":"1","key":"3709_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.027","volume":"26","author":"X Chen","year":"2017","unstructured":"Chen X, Wang Y, Fu M, Lei H, Cheng Q, Zhang X. Plasma Immunoproteasome predicts early hemorrhagic transformation in acute ischemic stroke patients. J Stroke Cerebrovasc. 2017;26(1):49\u201356.","journal-title":"J STROKE CEREBROVASC"},{"issue":"1","key":"3709_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li Y, Wang C, Han T, Liu H, Sun L, et al. The reciprocal interactions between microglia and T cells in parkinson\u2019s disease: a double-edged sword. J Neuroinflamm. 2023;20(1):33.","journal-title":"J NEUROINFLAMM"},{"issue":"1","key":"3709_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-022-02512-z","volume":"19","author":"S Park","year":"2022","unstructured":"Park S, Yang H, Ye M, Liu X, Shim I, Chang Y, et al. Neuroprotective effects of ex vivo-expanded regulatory T cells on trimethyltin-induced neurodegeneration in mice. J Neuroinflamm. 2022;19(1):143.","journal-title":"J NEUROINFLAMM"},{"key":"3709_CR59","doi-asserted-by":"publisher","first-page":"1047550","DOI":"10.3389\/fimmu.2022.1047550","volume":"13","author":"J Zeng","year":"2022","unstructured":"Zeng J, Bao T, Yang K, Zhu X, Wang S, Xiang W, et al. The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review. Front Immunol. 2022;13:1047550.","journal-title":"FRONT IMMUNOL"},{"issue":"2","key":"3709_CR60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nm.1927","volume":"15","author":"A Liesz","year":"2009","unstructured":"Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15(2):192\u20139.","journal-title":"NAT MED"},{"issue":"1","key":"3709_CR61","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1038\/s41467-025-62631-y","volume":"16","author":"A Schmidt-Pogoda","year":"2025","unstructured":"Schmidt-Pogoda A, Ruck T, Strecker JK, Hoppen M, Fazio L, Vinnenberg L, et al. Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signaling. Nat Commun. 2025;16(1):8928.","journal-title":"NAT COMMUN"},{"key":"3709_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainresbull.2023.03.005","volume":"196","author":"Y Wang","year":"2023","unstructured":"Wang Y, Cui W, Wu H, Xu X, Xu X. The role of T cells in acute ischemic stroke. Brain Res Bull. 2023;196:20\u201333.","journal-title":"BRAIN RES BULL"},{"issue":"8","key":"3709_CR63","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.4049\/jimmunol.1201183","volume":"189","author":"KW Kalim","year":"2012","unstructured":"Kalim KW, Basler M, Kirk CJ, Groettrup M. Immunoproteasome subunit LMP7 deficiency and Inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. J Immunol. 2012;189(8):4182\u201393.","journal-title":"J IMMUNOL"},{"issue":"2","key":"3709_CR64","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cei.13132","volume":"193","author":"Y Guo","year":"2018","unstructured":"Guo Y, Chen X, Li D, Liu H, Ding Y, Han R, et al. PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke. Clin Exp Immunol. 2018;193(2):194\u2013206.","journal-title":"CLIN EXP IMMUNOL"},{"issue":"5944","key":"3709_CR65","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1126\/science.1176077","volume":"325","author":"F Pan","year":"2009","unstructured":"Pan F, Yu H, Dang EV, Barbi J, Pan X, Grosso JF, et al. Eos mediates Foxp3-dependent gene Silencing in CD4\u2009+\u2009regulatory T cells. Science. 2009;325(5944):1142\u20136.","journal-title":"Science"},{"issue":"6","key":"3709_CR66","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/01.STR.0000126891.93919.4e","volume":"35","author":"C Wojcik","year":"2004","unstructured":"Wojcik C, Di Napoli M. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke. 2004;35(6):1506\u201318.","journal-title":"Stroke"},{"issue":"7","key":"3709_CR67","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1161\/01.STR.31.7.1686","volume":"31","author":"JB Phillips","year":"2000","unstructured":"Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke. 2000;31(7):1686\u201393.","journal-title":"Stroke"},{"issue":"7","key":"3709_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/BF03033160","volume":"5","author":"R Berti","year":"2003","unstructured":"Berti R, Williams AJ, Velarde LC, Moffett JR, Elliott PJ, Adams J, et al. Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat. Neurotox Res. 2003;5(7):505\u201314.","journal-title":"NEUROTOX RES"},{"issue":"2","key":"3709_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuint.2006.03.018","volume":"49","author":"AJ Williams","year":"2006","unstructured":"Williams AJ, Dave JR, Tortella FC. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappab (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem Int. 2006;49(2):106\u201312.","journal-title":"NEUROCHEM INT"},{"issue":"5","key":"3709_CR70","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/STROKEAHA.109.577288","volume":"41","author":"L Zhang","year":"2010","unstructured":"Zhang L, Zhang ZG, Buller B, Jiang J, Jiang Y, Zhao D, et al. Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia. Stroke. 2010;41(5):1001\u20137.","journal-title":"Stroke"},{"issue":"1","key":"3709_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1160\/TH05-07-0477","volume":"95","author":"L Zhang","year":"2006","unstructured":"Zhang L, Zhang ZG, Liu X, Hozeska A, Stagliano N, Riordan W, et al. Treatment of embolic stroke in rats with bortezomib and Recombinant human tissue plasminogen activator. Thromb Haemostasis. 2006;95(1):166\u201373.","journal-title":"THROMB HAEMOSTASIS"},{"issue":"5","key":"3709_CR72","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1161\/01.STR.0000125721.10606.dc","volume":"35","author":"AJ Williams","year":"2004","unstructured":"Williams AJ, Berti R, Dave JR, Elliot PJ, Adams J, Tortella FC. Delayed treatment of ischemia\/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke. 2004;35(5):1186\u201391.","journal-title":"Stroke"},{"key":"3709_CR73","doi-asserted-by":"crossref","unstructured":"Huber EM, Groll M. A nut for every bolt: Subunit-Selective inhibitors of the Immunoproteasome and their therapeutic potential. Cells. 2021;10(8):1929.","DOI":"10.3390\/cells10081929"},{"key":"3709_CR74","doi-asserted-by":"crossref","unstructured":"Wang J, Fang Y, Fan RA, Kirk CJ. Proteasome inhibitors and their Pharmacokinetics, Pharmacodynamics, and metabolism. Int J Mol Sci. 2021;22(21):11595.","DOI":"10.3390\/ijms222111595"},{"key":"3709_CR75","doi-asserted-by":"publisher","first-page":"1043680","DOI":"10.3389\/fimmu.2023.1043680","volume":"14","author":"T Muchamuel","year":"2023","unstructured":"Muchamuel T, Fan RA, Anderl JL, Bomba DJ, Johnson HWB, Lowe E, et al. Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses. Front Immunol. 2023;14:1043680.","journal-title":"FRONT IMMUNOL"},{"issue":"9","key":"3709_CR76","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/eji.202249851","volume":"52","author":"M Del Rio Oliva","year":"2022","unstructured":"Del Rio Oliva M, Kirk CJ, Groettrup M, Basler M. Effective therapy of polymyositis in mice via selective Inhibition of the Immunoproteasome. Eur J Immunol. 2022;52(9):1510\u201322.","journal-title":"EUR J IMMUNOL"},{"issue":"9","key":"3709_CR77","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1124\/dmd.120.000307","volume":"49","author":"Y Fang","year":"2021","unstructured":"Fang Y, Johnson H, Anderl JL, Muchamuel T, McMinn D, Morisseau C, et al. Role of epoxide hydrolases and cytochrome P450s on metabolism of KZR-616, a First-in-Class selective inhibitor of the Immunoproteasome. Drug Metab Dispos. 2021;49(9):810\u201321.","journal-title":"DRUG METAB DISPOS"},{"issue":"1","key":"3709_CR78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-017-0453-5","volume":"5","author":"LK Wagner","year":"2017","unstructured":"Wagner LK, Gilling KE, Schormann E, Kloetzel PM, Heppner FL, Kruger E, et al. Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in alzheimer\u2019s disease-like APPPS1 mice. Acta Neuropathol Com. 2017;5(1):52.","journal-title":"ACTA NEUROPATHOL COM"},{"issue":"5","key":"3709_CR79","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s12035-023-03231-z","volume":"60","author":"C Gong","year":"2023","unstructured":"Gong C, Bonfili L, Zheng Y, Cecarini V, Cuccioloni M, Angeletti M, et al. Immortalized alzheimer\u2019s disease astrocytes: characterization of their proteolytic systems. Mol Neurobiol. 2023;60(5):2787\u2013800.","journal-title":"MOL NEUROBIOL"},{"issue":"11","key":"3709_CR80","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","volume":"29","author":"BP Tseng","year":"2008","unstructured":"Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM. Abeta inhibits the proteasome and enhances amyloid and Tau accumulation. Neurobiol Aging. 2008;29(11):1607\u201318.","journal-title":"NEUROBIOL AGING"},{"key":"3709_CR81","doi-asserted-by":"crossref","unstructured":"Jiang S, Srikanth M, Serpe R, Yavari S, Gaur P, Collins GA, et al. Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer\u2019s disease. Brain. 2025;148(12):4372\u201388.","DOI":"10.1093\/brain\/awaf222"},{"issue":"2","key":"3709_CR82","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1582-4934.2008.00276.x","volume":"12","author":"S Oddo","year":"2008","unstructured":"Oddo S. The ubiquitin-proteasome system in alzheimer\u2019s disease. J Cell Mol Med. 2008;12(2):363\u201373.","journal-title":"J CELL MOL MED"},{"issue":"16","key":"3709_CR83","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1089\/ars.2016.6802","volume":"25","author":"V Bonet-Costa","year":"2016","unstructured":"Bonet-Costa V, Pomatto LC, Davies KJA. The proteasome and oxidative stress in alzheimer\u2019s disease. Antioxid Redox Sign. 2016;25(16):886\u2013901.","journal-title":"ANTIOXID REDOX SIGN"},{"key":"3709_CR84","doi-asserted-by":"publisher","first-page":"108329","DOI":"10.1016\/j.pharmthera.2022.108329","volume":"241","author":"GR Tundo","year":"2023","unstructured":"Tundo GR, Cascio P, Milardi D, Santoro AM, Graziani G, Lacal PM, et al. Targeting Immunoproteasome in neurodegeneration: A glance to the future. Pharmacol Therapeut. 2023;241:108329.","journal-title":"PHARMACOL THERAPEUT"},{"issue":"1","key":"3709_CR85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2004.12.004","volume":"27","author":"M Mishto","year":"2006","unstructured":"Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, et al. Immunoproteasome and LMP2 polymorphism in aged and alzheimer\u2019s disease brains. Neurobiol Aging. 2006;27(1):54\u201366.","journal-title":"NEUROBIOL AGING"},{"issue":"Pt 5","key":"3709_CR86","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/brain\/awt083","volume":"136","author":"M Orre","year":"2013","unstructured":"Orre M, Kamphuis W, Dooves S, Kooijman L, Chan ET, Kirk CJ, et al. Reactive glia show increased Immunoproteasome activity in alzheimer\u2019s disease. Brain. 2013;136(Pt 5):1415\u201331.","journal-title":"Brain"},{"issue":"4","key":"3709_CR87","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan Y, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in alzheimer disease. J Clin Investig. 2020;130(4):1912\u201330.","journal-title":"J Clin Investig"},{"issue":"1","key":"3709_CR88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","volume":"14","author":"I Ferrer","year":"2004","unstructured":"Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in alzheimer\u2019s disease. Brain Pathol. 2004;14(1):11\u201320.","journal-title":"BRAIN PATHOL"},{"issue":"10","key":"3709_CR89","doi-asserted-by":"publisher","first-page":"e70746","DOI":"10.1002\/alz.70746","volume":"21","author":"G Povala","year":"2025","unstructured":"Povala G, Bellaver B, Bastiani MAD, Ferrari-Souza JP, Aguzzoli CS, Leffa DT, et al. Amyloid beta and Tau are associated with the dual effect of neuroinflammation on neurodegeneration. Alzheimers Dement. 2025;21(10):e70746.","journal-title":"ALZHEIMERS DEMENT"},{"key":"3709_CR90","doi-asserted-by":"publisher","first-page":"982786","DOI":"10.3389\/fimmu.2022.982786","volume":"13","author":"G Cetin","year":"2022","unstructured":"Cetin G, Studencka-Turski M, Venz S, Schormann E, Junker H, Hammer E, et al. Immunoproteasomes control activation of innate immune signaling and microglial function. Front Immunol. 2022;13:982786.","journal-title":"FRONT IMMUNOL"},{"issue":"1","key":"3709_CR91","doi-asserted-by":"publisher","first-page":"18393","DOI":"10.1038\/s41598-019-54846-z","volume":"9","author":"IJ Yeo","year":"2019","unstructured":"Yeo IJ, Lee MJ, Baek A, Miller Z, Bhattarai D, Baek YM, et al. A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of alzheimer\u2019s disease. Sci Rep-UK. 2019;9(1):18393.","journal-title":"SCI REP-UK"},{"key":"3709_CR92","doi-asserted-by":"crossref","unstructured":"Cetin G, Klafack S, Studencka-Turski M, Kruger E, Ebstein F. The Ubiquitin-Proteasome system in immune cells. Biomolecules. 2021;11(1):60.","DOI":"10.3390\/biom11010060"},{"key":"3709_CR93","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3389\/fimmu.2018.02386","volume":"9","author":"C Schmidt","year":"2018","unstructured":"Schmidt C, Berger T, Groettrup M, Basler M. Immunoproteasome Inhibition impairs T and B cell activation by restraining ERK signaling and proteostasis. Front Immunol. 2018;9:2386.","journal-title":"FRONT IMMUNOL"},{"issue":"10","key":"3709_CR94","doi-asserted-by":"publisher","first-page":"8481","DOI":"10.1007\/s12035-024-03972-5","volume":"61","author":"Y Guo","year":"2024","unstructured":"Guo Y, Wang S, Li L, Zhang H, Chen X, Huang Z, et al. Correction: Immunoproteasome subunit low molecular mass peptide 2 (LMP2) deficiency ameliorates LPS\/Abeta1-42-Induced neuroinflammation. Mol Neurobiol. 2024;61(10):8481\u20132.","journal-title":"MOL NEUROBIOL"},{"issue":"7","key":"3709_CR95","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1021\/acs.jmedchem.0c00416","volume":"63","author":"D Bhattarai","year":"2020","unstructured":"Bhattarai D, Lee MJ, Baek A, Yeo IJ, Miller Z, Baek YM, et al. LMP2 inhibitors as a potential treatment for alzheimer\u2019s disease. J Med Chem. 2020;63(7):3763\u201383.","journal-title":"J MED CHEM"},{"issue":"15","key":"3709_CR96","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1021\/acs.jmedchem.1c00291","volume":"64","author":"MJ Lee","year":"2021","unstructured":"Lee MJ, Bhattarai D, Jang H, Baek A, Yeo IJ, Lee S, et al. Macrocyclic Immunoproteasome inhibitors as a potential therapy for alzheimer\u2019s disease. J Med Chem. 2021;64(15):10934\u201350.","journal-title":"J MED CHEM"},{"issue":"9","key":"3709_CR97","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1021\/acs.jmedchem.3c02488","volume":"67","author":"JE Park","year":"2024","unstructured":"Park JE, Chaudhary CL, Bhattarai D, Kim KB. Brain-Permeable Immunoproteasome-Targeting macrocyclic peptide epoxyketones for alzheimer\u2019s disease. J Med Chem. 2024;67(9):7146\u201357.","journal-title":"J MED CHEM"},{"issue":"1","key":"3709_CR98","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-020-09973-0","volume":"16","author":"A Maltsev","year":"2021","unstructured":"Maltsev A, Funikov S, Burov A, Spasskaya D, Ignatyuk V, Astakhova T, et al. Immunoproteasome inhibitor ONX-0914 affects Long-Term potentiation in murine hippocampus. J Neuroimmune Pharm. 2021;16(1):7\u201311.","journal-title":"J NEUROIMMUNE PHARM"},{"key":"3709_CR99","doi-asserted-by":"crossref","unstructured":"Basler M, Lindstrom MM, LaStant JJ, Bradshaw JM, Owens TD, Schmidt C, et al. Co-inhibition of Immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity. Embo Rep. 2018;19(12):e46512.","DOI":"10.15252\/embr.201846512"},{"issue":"11","key":"3709_CR100","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"NAT REV IMMUNOL"},{"issue":"Pt B","key":"3709_CR101","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in parkinson\u2019s disease. Neurobiol Dis. 2018;109(Pt B):249\u201357.","journal-title":"NEUROBIOL DIS"},{"key":"3709_CR102","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fnins.2018.00388","volume":"12","author":"M Vicario","year":"2018","unstructured":"Vicario M, Cieri D, Brini M, Cali T. The close encounter between Alpha-Synuclein and mitochondria. Front Neurosci-switz. 2018;12:388.","journal-title":"FRONT NEUROSCI-SWITZ"},{"key":"3709_CR103","doi-asserted-by":"publisher","first-page":"1498756","DOI":"10.3389\/fnagi.2024.1498756","volume":"16","author":"Y Luo","year":"2024","unstructured":"Luo Y, Qiao L, Li M, Wen X, Zhang W, Li X. Global, regional, National epidemiology and trends of parkinson\u2019s disease from 1990 to 2021: findings from the global burden of disease study 2021. Front Aging Neurosci. 2024;16:1498756.","journal-title":"FRONT AGING NEUROSCI"},{"key":"3709_CR104","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebrian","year":"2014","unstructured":"Cebrian C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun. 2014;5:3633.","journal-title":"NAT COMMUN"},{"issue":"7660","key":"3709_CR105","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"issue":"1","key":"3709_CR106","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12974-016-0606-7","volume":"13","author":"S Wang","year":"2016","unstructured":"Wang S, Chu C, Guo M, Jiang L, Nie H, Zhang W, et al. Identification of a specific alpha-synuclein peptide (alpha-Syn 29\u201340) capable of eliciting microglial superoxide production to damage dopaminergic neurons. J Neuroinflamm. 2016;13(1):158.","journal-title":"J NEUROINFLAMM"},{"key":"3709_CR107","doi-asserted-by":"publisher","first-page":"105990","DOI":"10.1016\/j.ebiom.2025.105990","volume":"121","author":"HD Nguyen","year":"2025","unstructured":"Nguyen HD, Tram Tran HB, Nguyen TT, Kwak IH, Kim YJ, Ma H, et al. Pathological role of Immunoproteasome PSMB8 in parkinson\u2019s disease: a link between \u03b1-synuclein aggregation and immune activation. Ebiomedicine. 2025;121:105990.","journal-title":"EBIOMEDICINE"},{"issue":"3","key":"3709_CR108","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14(3):176.","journal-title":"CELL DEATH DIS"},{"key":"3709_CR109","doi-asserted-by":"publisher","first-page":"135360","DOI":"10.1016\/j.neulet.2020.135360","volume":"738","author":"C Sun","year":"2020","unstructured":"Sun C, Jia G, Wang X, Wang Y, Liu Y. Immunoproteasome is up-regulated in rotenone-induced parkinson\u2019s disease rat model. Neurosci Lett. 2020;738:135360.","journal-title":"NEUROSCI LETT"},{"key":"3709_CR110","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ebiom.2018.05.007","volume":"31","author":"S Ugras","year":"2018","unstructured":"Ugras S, Daniels MJ, Fazelinia H, Gould NS, Yocum AK, Luk KC, et al. Induction of the Immunoproteasome subunit Lmp7 links proteostasis and immunity in alpha-Synuclein aggregation disorders. Ebiomedicine. 2018;31:307\u201319.","journal-title":"EBIOMEDICINE"},{"key":"3709_CR111","doi-asserted-by":"publisher","first-page":"1124907","DOI":"10.3389\/fcell.2023.1124907","volume":"11","author":"K Davidson","year":"2023","unstructured":"Davidson K, Pickering AM. The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease. Front Cell Dev Biol. 2023;11:1124907.","journal-title":"FRONT CELL DEV BIOL"},{"key":"3709_CR112","doi-asserted-by":"publisher","first-page":"102167","DOI":"10.1016\/j.redox.2021.102167","volume":"47","author":"M Bi","year":"2021","unstructured":"Bi M, Du X, Xiao X, Dai Y, Jiao Q, Chen X, et al. Deficient Immunoproteasome assembly drives gain of alpha-synuclein pathology in parkinson\u2019s disease. Redox Biol. 2021;47:102167.","journal-title":"REDOX BIOL"},{"issue":"2","key":"3709_CR113","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.expneurol.2005.08.027","volume":"196","author":"K Puttaparthi","year":"2005","unstructured":"Puttaparthi K, Elliott JL. Non-neuronal induction of Immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol. 2005;196(2):441\u201351.","journal-title":"EXP NEUROL"},{"issue":"1","key":"3709_CR114","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/hmg\/ddn319","volume":"18","author":"C Cheroni","year":"2009","unstructured":"Cheroni C, Marino M, Tortarolo M, Veglianese P, De Biasi S, Fontana E, et al. Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of Familial amyotrophic lateral sclerosis. Hum Mol Genet. 2009;18(1):82\u201396.","journal-title":"HUM MOL GENET"},{"issue":"5","key":"3709_CR115","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4103\/1673-5374.385283","volume":"19","author":"P Tarot","year":"2024","unstructured":"Tarot P, Lasbleiz C, Lievens J. NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality. Neural Regen Res. 2024;19(5):1006\u201312.","journal-title":"NEURAL REGEN RES"},{"issue":"4","key":"3709_CR116","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/10409238.2016.1172554","volume":"51","author":"HK Johnston-Carey","year":"2015","unstructured":"Johnston-Carey HK, Pomatto LCD, Davies KJA. The Immunoproteasome in oxidative stress, aging, and disease. Crit Rev Biochem Mol. 2015;51(4):268\u201381.","journal-title":"CRIT REV BIOCHEM MOL"},{"issue":"2","key":"3709_CR117","doi-asserted-by":"publisher","first-page":"fcaa124","DOI":"10.1093\/braincomms\/fcaa124","volume":"2","author":"L Beland","year":"2020","unstructured":"Beland L, Markovinovic A, Jakovac H, De Marchi F, Bilic E, Mazzini L, et al. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020;2(2):fcaa124.","journal-title":"BRAIN COMMUN"},{"issue":"37","key":"3709_CR118","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1523\/JNEUROSCI.23-37-11653.2003","volume":"23","author":"M Diaz-Hernandez","year":"2003","unstructured":"Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, et al. Neuronal induction of the Immunoproteasome in huntington\u2019s disease. J Neurosci. 2003;23(37):11653\u201361.","journal-title":"J NEUROSCI"},{"issue":"6","key":"3709_CR119","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/BF03033282","volume":"6","author":"M Diaz-Hernandez","year":"2004","unstructured":"Diaz-Hernandez M, Martin-Aparicio E, Avila J, Hernandez F, Lucas JJ. Enhanced induction of the Immunoproteasome by interferon gamma in neurons expressing mutant Huntingtin. Neurotox Res. 2004;6(6):463\u20138.","journal-title":"NEUROTOX RES"},{"key":"3709_CR120","doi-asserted-by":"publisher","first-page":"1107323","DOI":"10.3389\/fmolb.2023.1107323","volume":"10","author":"KA Sap","year":"2023","unstructured":"Sap KA, Geijtenbeek KW, Schipper-Krom S, Guler AT, Reits EA. Ubiquitin-modifying enzymes in huntington\u2019s disease. Front Mol Biosci. 2023;10:1107323.","journal-title":"FRONT MOL BIOSCI"},{"key":"3709_CR121","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","volume":"7","author":"Z Ortega","year":"2014","unstructured":"Ortega Z, Lucas JJ. Ubiquitin-proteasome system involvement in huntington\u2019s disease. Front Mol Neurosci. 2014;7:77.","journal-title":"FRONT MOL NEUROSCI"},{"issue":"1","key":"3709_CR122","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s41467-020-16625-7","volume":"11","author":"AM Agasing","year":"2020","unstructured":"Agasing AM, Wu Q, Khatri B, Borisow N, Ruprecht K, Brandt AU, et al. Transcriptomics and proteomics reveal a Cooperation between interferon and T-helper 17 cells in neuromyelitis Optica. Nat Commun. 2020;11(1):2856.","journal-title":"NAT COMMUN"},{"key":"3709_CR123","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.msard.2019.01.047","volume":"30","author":"L Brill","year":"2019","unstructured":"Brill L, Lavon I, Vaknin-Dembinsky A. Foxp3\u2009+\u2009regulatory T cells expression in neuromyelitis Optica spectrum disorders. Mult Scler Relat Dis. 2019;30:114\u20138.","journal-title":"MULT SCLER RELAT DIS"},{"issue":"5","key":"3709_CR124","doi-asserted-by":"publisher","first-page":"e126768","DOI":"10.1371\/journal.pone.0126768","volume":"10","author":"NJ Schuld","year":"2015","unstructured":"Schuld NJ, Hussong SA, Kapphahn RJ, Lehmann U, Roehrich H, Rageh AA, et al. Immunoproteasome deficiency protects in the retina after optic nerve crush. PLoS ONE. 2015;10(5):e126768.","journal-title":"PLoS ONE"},{"key":"3709_CR125","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.expneurol.2013.02.005","volume":"247","author":"R Khorooshi","year":"2013","unstructured":"Khorooshi R, Wlodarczyk A, Asgari N, Owens T. Neuromyelitis optica-like pathology is dependent on type I interferon response. Exp Neurol. 2013;247:744\u20137. https:\/\/doi.org\/10.1016\/j.expneurol.2013.02.005.","journal-title":"EXP NEUROL"},{"issue":"8","key":"3709_CR126","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/jamaneurol.2017.1336","volume":"74","author":"C Zhang","year":"2017","unstructured":"Zhang C, Tian D, Yang C, Han B, Wang J, Yang L, et al. Safety and efficacy of bortezomib in patients with highly relapsing neuromyelitis Optica spectrum disorder. Jama Neurol. 2017;74(8):1010\u20132.","journal-title":"JAMA NEUROL"},{"key":"3709_CR127","doi-asserted-by":"crossref","unstructured":"Dos Passos GR, Sato DK, Becker J, Fujihara K. Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications. Mediat Inflamm. 2016: 5314541.","DOI":"10.1155\/2016\/5314541"},{"issue":"1","key":"3709_CR128","first-page":"fcae17","volume":"6","author":"H Leister","year":"2024","unstructured":"Leister H, Krause FF, Gil B, Prus R, Prus I, Hellhund-Zingel A, et al. Immunoproteasome deficiency results in age-dependent development of epilepsy. Brain Commun. 2024;6(1):fcae17.","journal-title":"BRAIN COMMUN"},{"issue":"1","key":"3709_CR129","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2011.03.117","volume":"408","author":"M Mishto","year":"2011","unstructured":"Mishto M, Ligorio C, Bellavista E, Martucci M, Santoro A, Giulioni M, et al. Immunoproteasome expression is induced in mesial Temporal lobe epilepsy. Biochem Bioph Res Co. 2011;408(1):65\u201370.","journal-title":"BIOCHEM BIOPH RES CO"},{"issue":"Suppl 3","key":"3709_CR130","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/epi.13783","volume":"58","author":"E Aronica","year":"2017","unstructured":"Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia. 2017;58(Suppl 3):27\u201338.","journal-title":"EPILEPSIA"},{"issue":"1","key":"3709_CR131","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12974-016-0662-z","volume":"13","author":"J van Scheppingen","year":"2016","unstructured":"van Scheppingen J, Broekaart DWM, Scholl T, Zuidberg MRJ, Anink JJ, Spliet WG, et al. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development. J Neuroinflamm. 2016;13(1):202.","journal-title":"J NEUROINFLAMM"},{"key":"3709_CR132","unstructured":"Tafti D, Ehsan M, Xixis KL. Multiple Sclerosis. 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/29763024\/."},{"issue":"2","key":"3709_CR133","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17(2):210\u20138.","journal-title":"BRAIN PATHOL"},{"issue":"7","key":"3709_CR134","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuron.2021.12.034","volume":"110","author":"M Meijer","year":"2022","unstructured":"Meijer M, Agirre E, Kabbe M, van Tuijn CA, Heskol A, Zheng C, et al. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility. Neuron. 2022;110(7):1193\u2013210.","journal-title":"Neuron"},{"key":"3709_CR135","doi-asserted-by":"crossref","unstructured":"Bellavista E, Santoro A, Galimberti D, Comi C, Luciani F, Mishto M. Current understanding on the role of standard and immunoproteasomes in inflammatory\/immunological pathways of multiple sclerosis. Autoimmun Dis. 2014:739705.","DOI":"10.1155\/2014\/739705"},{"key":"3709_CR136","doi-asserted-by":"publisher","first-page":"1379261","DOI":"10.3389\/fncel.2024.1379261","volume":"18","author":"BC Shaw","year":"2024","unstructured":"Shaw BC, Williams JL. A novel PSMB8 isoform associated with multiple sclerosis lesions induces P-body formation. Front Cell Neurosci. 2024;18:1379261.","journal-title":"FRONT CELL NEUROSCI"},{"issue":"17","key":"3709_CR137","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1016\/j.cell.2025.05.029","volume":"188","author":"MS Woo","year":"2025","unstructured":"Woo MS, Brand J, Bal LC, Moritz M, Walkenhorst M, Vieira V, et al. The Immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis. Cell. 2025;188(17):4567\u201385.","journal-title":"Cell"},{"issue":"1","key":"3709_CR138","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat Commun. 2019;10(1):3887.","journal-title":"NAT COMMUN"},{"issue":"2","key":"3709_CR139","doi-asserted-by":"publisher","first-page":"e9287","DOI":"10.1371\/journal.pone.0009287","volume":"5","author":"M Mishto","year":"2010","unstructured":"Mishto M, Bellavista E, Ligorio C, Textoris-Taube K, Santoro A, Giordano M, et al. Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS ONE. 2010;5(2):e9287.","journal-title":"PLoS ONE"},{"key":"3709_CR140","doi-asserted-by":"crossref","unstructured":"Kirk CJ, Muchamuel T, Wang J, Fan RA. Discovery and early clinical development of selective Immunoproteasome inhibitors. Cells. 2021;11(1):9.","DOI":"10.3390\/cells11010009"},{"issue":"12","key":"3709_CR141","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/0929867323666160318173706","volume":"23","author":"R Ettari","year":"2016","unstructured":"Ettari R, Previti S, Bitto A, Grasso S, Zappala M. Immunoproteasome-Selective inhibitors: A promising strategy to treat hematologic Malignancies, autoimmune and inflammatory diseases. Curr Med Chem. 2016;23(12):1217\u201338.","journal-title":"CURR MED CHEM"},{"issue":"9","key":"3709_CR142","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1111\/jnc.16165","volume":"168","author":"E Gorska","year":"2024","unstructured":"Gorska E, Tylicka M, Kaminska J, Hermanowicz A, Matuszczak E, Oldak L, et al. 20S constitutive proteasome, 20S immunoproteasome, and cathepsin S are high-sensitivity and independent markers of immunological activity in relapsing-remitting type of multiple sclerosis. J Neurochem. 2024;168(9):2880\u201392.","journal-title":"J NEUROCHEM"},{"key":"3709_CR143","doi-asserted-by":"crossref","unstructured":"Di Filippo M, Gaetani L, Centonze D, Hegen H, Kuhle J, Teunissen CE, et al. Fluid biomarkers in multiple sclerosis: from current to future applications. Lancet Reg Health-EU. 2024;44:p.101009.","DOI":"10.1016\/j.lanepe.2024.101009"},{"key":"3709_CR144","unstructured":"Shumway CL, Patel BC, Tripathy K, De Jesus O. Neuromyelitis Optica Spectrum Disorder (NMOSD). 2025. Bookshelf ID: NBK572108. https:\/\/pubmed.ncbi.nlm.nih.gov\/34283474\/."},{"issue":"4","key":"3709_CR145","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","volume":"2","author":"A Zekeridou","year":"2015","unstructured":"Zekeridou A, Lennon VA. Aquaporin-4 autoimmunity. Neurol-Neuroimmunol. 2015;2(4):e110.","journal-title":"NEUROL-NEUROIMMUNOL"},{"key":"3709_CR146","doi-asserted-by":"publisher","first-page":"867357","DOI":"10.3389\/fnins.2022.867357","volume":"16","author":"MM Madeira","year":"2022","unstructured":"Madeira MM, Hage Z, Tsirka SE. Beyond myelination: possible roles of the immune proteasome in oligodendroglial homeostasis and dysfunction. Front Neurosci-Switz. 2022;16:867357.","journal-title":"FRONT NEUROSCI-SWITZ"},{"key":"3709_CR147","doi-asserted-by":"publisher","first-page":"104684","DOI":"10.1016\/j.yexmp.2021.104684","volume":"123","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hu W, Liu Q, Ma Z, Hu S, Zhang Z, et al. Expression of Immunoproteasome subunits in the brains of Toxoplasma gondii-infected mice. Exp Mol Pathol. 2021;123:104684.","journal-title":"EXP MOL PATHOL"},{"key":"3709_CR148","doi-asserted-by":"publisher","first-page":"619465","DOI":"10.3389\/fimmu.2021.619465","volume":"12","author":"T French","year":"2021","unstructured":"French T, Israel N, Dusedau HP, Tersteegen A, Steffen J, Cammann C, et al. The Immunoproteasome subunits LMP2, LMP7 and MECL-1 are crucial along the induction of cerebral toxoplasmosis. Front Immunol. 2021;12:619465.","journal-title":"FRONT IMMUNOL"},{"issue":"2","key":"3709_CR149","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani A, Fujinami RS, White HS, Preux P, Blumcke I, Sander JW, et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131(2):211\u201334.","journal-title":"ACTA NEUROPATHOL"},{"issue":"4","key":"3709_CR150","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/15357597241253503","volume":"24","author":"NH Varvel","year":"2024","unstructured":"Varvel NH. Takin\u2019 out the trash for brain Health! Epilepsy Curr. 2024;24(4):292\u20134.","journal-title":"EPILEPSY CURR"},{"key":"3709_CR151","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fimmu.2019.00628","volume":"10","author":"F Limanaqi","year":"2019","unstructured":"Limanaqi F, Biagioni F, Gaglione A, Busceti CL, Fornai F. A Sentinel in the crosstalk between the nervous and immune system: the (Immuno)-Proteasome. Front Immunol. 2019;10:628. https:\/\/doi.org\/10.3389\/fimmu.2019.00628.","journal-title":"FRONT IMMUNOL"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03709-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:02:47Z","timestamp":1773064967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03709-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3709"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03709-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}